33 None of the mechanisms alone explains all the metabolic abnormalities observed in HIV-infected patients receiving HAART, pointing to a multifactorial process and the need for further research.
Although it is known that nucleoside and nonnucleoside reverse transcriptase inhibitors also may affect lipid metabolism, the mechanisms are not yet known.